Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
about
Thrombocytopenia and thrombosis: a double-edged sword.Identification of novel biomarkers in chronic immune thrombocytopenia (ITP) by microarray-based serum protein profiling.Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia.Prognostic significance of platelet count in SLE patients.Expression, purification and biological activity assessment of romiplostim biosimilar peptibody
P2860
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@ast
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@en
type
label
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@ast
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@en
prefLabel
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@ast
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@en
P1476
Autoimmunity and novel therapies in immune-mediated thrombocytopenia.
@en
P2093
Dana Yehudai
Zahava Vadasz
P304
P356
10.1053/J.SEMINHEMATOL.2013.03.015
P478
50 Suppl 1
P577
2013-01-01T00:00:00Z